FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA: Preliminary Results From a Phase I/II Clinical Treatment Trial. (Record no. 27970814)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02315 a2200625 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517194150.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 202004s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1539-2864 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1097/IAE.0000000000002027 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Nti, Akosua A |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20200427 |
245 00 - TITLE STATEMENT | |
Title | FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA: Preliminary Results From a Phase I/II Clinical Treatment Trial. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Retina (Philadelphia, Pa.) |
Date of publication, distribution, etc. | Mar 2019 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 502-513 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Enzyme Inhibitors |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hydroxychloroquine |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Imidazoles |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | MAP Kinase Kinase 1 |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Macula Lutea |
General subdivision | pathology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Melanoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oximes |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Photoreceptor Cells |
General subdivision | pathology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein Kinase Inhibitors |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proto-Oncogene Proteins B-raf |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyridones |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrimidinones |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Retinal Diseases |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Retinal Pigment Epithelium |
General subdivision | pathology |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Serrano, Leona W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sandhu, Harpal S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Uyhazi, Katherine E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Edelstein, Ilaina D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zhou, Elaine J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bowman, Scott |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Song, Delu |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gangadhar, Tara C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schuchter, Lynn M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mitnick, Sheryl |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Huang, Alexander |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nichols, Charles W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Amaravadi, Ravi K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kim, Benjamin J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Aleman, Tomas S |
773 0# - HOST ITEM ENTRY | |
Title | Retina (Philadelphia, Pa.) |
Related parts | vol. 39 |
-- | no. 3 |
-- | p. 502-513 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1097/IAE.0000000000002027">https://doi.org/10.1097/IAE.0000000000002027</a> |
Public note | Available from publisher's website |
No items available.